Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Comments
Loading...

U.S. stock futures were lower this morning, with the Dow futures falling more than 250 points on Tuesday.

Shares of AECOM ACM fell sharply in today's pre-market trading following fourth-quarter results.

The company reported better-than-expected earnings for its fourth quarter. The company’s quarterly earnings came in at $1.27 per share which beat the analyst consensus estimate of $1.24 per share. The company reported quarterly sales of $4.11 billion versus the analyst consensus estimate of $4.14 billion.

Aecom shares declined 3.3% to $105.50 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Hanmi Financial Corporation HAFC shares tumbled 20.9% to $20.24 in pre-market trading.
  • Guardian Pharmacy Services, Inc. GRDN fell 20.7% to $16.96 in pre-market trading.
  • Flushing Financial Corporation FFIC declined 12.2% to $15.25 in pre-market trading.
  • Incyte Corporation INCY fell 10.3% to $68.98 in today's pre-market trading after the company issued an update on early Phase MRGPRX2 and MRGPRX4 programs.
  • Grifols, S.A. GRFS shares declined 9.1% to $8.38 in pre-market trading.
  • Nexxen International Ltd. NEXN shares fell 7.3% to $8.37 in pre-market trading after jumping over 20% on Monday.
  • Trump Media & Technology Group Corp. DJT fell 5.8% to $30.86 in pre-market trading after jumping around 17% on Monday.
  • Globalstar, Inc. GSAT shares fell 5.8% to $1.61 in pre-market trading. Globalstar announced its board of directors authorized a reverse stock split of its common stock.

Now Read This:

Got Questions? Ask
Which AECOM projects could drive future growth?
How might Hanmi Financial recover after a sharp drop?
What implications does Guardian Pharmacy’s decline have on the pharmacy sector?
Is Flushing Financial positioned for a rebound in Q1?
What are the potential impacts of Incyte's Phase updates on biotech investments?
How could Grifols’ performance affect the biotech market?
What factors led to Nexxen International’s volatility recently?
What does the market think about Trump Media’s stock fluctuations?
How might Globalstar’s reverse split affect investor sentiment?
Which sectors are most vulnerable to market fluctuations this quarter?
Market News and Data brought to you by Benzinga APIs

Posted In: